Natalie S. Callander, MD, on Multiple Myeloma: Management Updates

April 17, 2024 By The ASCO Post Staff

Natalie S. Callander, MD, of the University of Wisconsin Carbone Cancer Center, discusses advances in the treatment of patients with multiple myeloma, including her commentary on smoldering disease, the early use of CAR T-cell therapy, quadruplet therapy, and the use of multiple lines of treatment over the disease course.

Related Content